Deepening Cisplatin sensitivity on Oral Squamous cell Carcinoma cell lines after PON2 knockdown: A FTIRM investigation
Open Access
- 9 January 2025
- journal article
- research article
- Published by Elsevier in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
- Vol. 330, 125726
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- The role of paraoxonase in cancerSeminars in Cancer Biology, 2019
- Oral tongue carcinoma among young patients: An analysis of risk factors and survivalOral Oncology, 2018
- In vitro FTIR microspectroscopy analysis of primary oral squamous carcinoma cells treated with cisplatin and 5-fluorouracil: a new spectroscopic approach for studying the drug–cell interactionThe Analyst, 2018
- Differential resistance to platinum‐based drugs and 5‐fluorouracil in p22phox‐overexpressing oral squamous cell carcinoma: Implications of alternative treatment strategiesHead & Neck, 2017
- Contribution of Ribonucleic Acid (RNA) to the Fourier Transform Infrared (FTIR) Spectrum of Eukaryotic CellsAnalytical Chemistry, 2016
- Cisplatin in cancer therapy: Molecular mechanisms of actionEuropean Journal of Pharmacology, 2014
- Targeted therapies for squamous cell carcinoma of the head and neck: Current knowledge and future directionsCancer Treatment Reviews, 2014
- Evidence of lipid peroxidation and protein phosphorylation in cells upon oxidative stress photo-generated by fullerolsBiophysical Chemistry, 2010
- Antimicrobial spectrum of the antitumor agent, cisplatinThe Journal of Antibiotics, 2010
- A library of IR bands of nucleic acids in solutionBiophysical Chemistry, 2003